(MedPage Today) — Local consolidative therapy (LCT) after induction treatment with nivolumab (Opdivo) plus ipilimumab (Yervoy) failed to improve survival outcomes in patients with metastatic non-small cell lung cancer (NSCLC), including those…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
